No black box warning on record for Cabtreo

As of the latest FDA labeling reviewed, Cabtreo (CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE/ADAPALENE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Cabtreo medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity : If a serious hypersensitivity reaction occurs, discontinue CABTREO immediately and initiate appropriate therapy. ( 5.1 ) Colitis : Clindamycin can cause severe colitis, which may result in death. Discontinue CABTREO if diarrhea occurs. ( 5.2 ) Photosensitivity : Avoid or minimize exposure to sunlight and sunlamps. Wear sunscreen and protective clothing

No black box warning on record for Cabtreo

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity : If a serious hypersensitivity reaction occurs, discontinue CABTREO immediately and initiate appropriate therapy. ( 5.1 ) Colitis : Clindamycin can cause severe colitis, which may result in death. Discontinue CABTREO if diarrhea occurs. ( 5.2 ) Photosensitivity : Avoid or minimize exposure to sunlight and sunlamps. Wear sunscreen and protective clothing

Cabtreo Black Box Warning

No black box warning on record for Cabtreo

Other warnings & precautions

Cabtreo Black Box Warning

No black box warning on record for Cabtreo

Other warnings & precautions